Mycophenolate mofetil decreases the risk for chronic renal allograft failure

Transplant Proc. 2001 Feb-Mar;33(1-2):1005-6. doi: 10.1016/s0041-1345(00)02305-8.

Authors

H Meier-Kriesche¹, A O Ojo, J A Arndorfer, J C Magee, D M Cibrik, A B Leichtman, D A Campbell, B Kaplan

Affiliation

¹ Department of Internal Medicine, University of Michigan, Medical Center, Ann Arbor, Michigan, USA.

PMID: 11267165
DOI: 10.1016/s0041-1345(00)02305-8

No abstract available

MeSH terms

Azathioprine / therapeutic use
Chronic Disease
Cyclosporine / therapeutic use
Graft Rejection / drug therapy*
Graft Rejection / epidemiology
Humans
Immunosuppressive Agents / therapeutic use*
Kidney Transplantation / immunology*
Kidney Transplantation / statistics & numerical data
Multivariate Analysis
Mycophenolic Acid / analogs & derivatives
Mycophenolic Acid / therapeutic use*
Proportional Hazards Models
Registries
Risk Factors
Transplantation, Homologous
United States / epidemiology

Substances

Immunosuppressive Agents
Cyclosporine
Mycophenolic Acid
Azathioprine